Wellspect HealthCare Introduces LoFric® Origo™ Pro – Featuring 12 Smooth Eyelets
Mölndal, Sweden – June 4, 2026 – Wellspect HealthCare introduces LoFric® Origo™ Pro – featuring 12 smooth eyelets designed to support complete bladder emptying and therefore reduce one of the key risk factors for urinary tract infections.
Wellspect HealthCare today announces the launch of LoFric® Origo™ Pro. It is a single-use hydrophilic intermittent catheter for men, featuring 12 smooth Pro eyelets designed to allow for complete bladder emptying in a single uninterrupted flow. Built on the proven long-term safety, high user satisfaction, and well-liked design of LoFric® catheters[1],[2], LoFric® Origo™ Pro will further simplify catheterization, supporting greater confidence for men in need of intermittent catheterization as part of their daily lives[3].
“The 12 smooth Pro eyelets are designed to support continuous, unobstructed flow, enabling effective drainage of urine, sediment, and solid particles without repositioning the catheter,” said Jan Hörling, Vice President Medical Affairs & Market Access, Wellspect HealthCare. “From a clinical perspective, this helps address a key challenge in intermittent catheterization, as complete bladder emptying is an important factor in reducing the risk of urinary tract infections[4].”
Clinical experience and published evidence suggest that the initial catheterization experience can play an important role in building confidence and familiarity with intermittent catheterization[5]. LoFric® Origo™ Pro simplifies learning, allowing healthcare professionals to focus less on technique and more on individual needs and patient confidence[3].
“LoFric® Origo™ Pro is designed to deliver reliable performance that healthcare professionals and their patients can trust from the very first use and throughout the daily routine,” said Vincent Maes, Vice President Commercial, Wellspect HealthCare. “LoFric® Origo™ Pro combines the benefits of multiple eyelets with the ability to completely drain both urine and particles. While many catheters require rotation or adjustment to achieve full emptying, its 12 smooth eyelets enable efficient drainage in one position – no twisting, no second-guessing. This makes the experience simpler from the start and builds confidence over time.”
With the introduction of LoFric® Origo™ Pro – following the launch of LoFric® Elle™ Pro – Wellspect now offers multiple Pro eyelets in catheters for both men and women.
“This marks an important step in Wellspect HealthCare’s continued effort to support better bladder health and improve quality of life through easy-to-use, reliable solutions[6] for people managing continence care needs,” said Chris Schlenk, Group Vice President, Wellspect HealthCare.
LoFric® Origo™ Pro will be introduced gradually across markets during 2026.
To learn more, please visit the LoFric® Origo™ Pro web page.
[1] Taffo et al., BJUI Compass, 2026
[2] Koeter et al., Nurs Open, 2019
[3] LoFric Origo Sleeve* Survey of 362 male intermittent catheter users across, UK, DE, FR, NL, SP, IT, DK during 2024 and 2025. Data on file at info@wellspect.com *LoFric Origo Sleeve and LoFric Origo Pro share the same features; the difference lies in the size and number of the eyelets: 2 or 12 eyelets.
[4] Hooton, N Engl J Med., 2012
[5] Seth et al., Patient Prefer Adherence, 2014
[6] Newman et al., Int Urol. Nephrol, 2020
For more details, please contact:
Marion Par-Weixlberger | Vice President Public Relations, Corporate Communications & Brand
Sirona Straße 1 | 5071 Wals bei Salzburg | Austria
T +43 (0) 662 2450-588 | F +43 (0) 662 2450-540
publicrelations@dentsplysirona.com
About Wellspect HealthCare
Wellspect HealthCare, a subsidiary of Dentsply Sirona, is a leading global provider of innovative medical devices dedicated to improving the quality of life for individuals with bladder and bowel dysfunction.
With approximately 1,200 employees worldwide, Wellspect is committed to making a real difference for people managing continence care needs, empowering them to live each day to the fullest.
Wellspect delivers solutions that support safe bladder and bowel management, while continuously enhancing the experience, clinical performance, and service quality for both healthcare professionals and the people in their care.
As one of the world’s leading manufacturers of intermittent urinary catheters, Wellspect has been at the forefront of innovation since 1983 with its LoFric® brand, which introduced the first hydrophilic-coated catheter.
Wellspect has also pioneered the development of Navina™, an innovative transanal irrigation system designed to support individuals living with chronic bowel disorders.
With advanced Surity™, Wellspect provides reliable urinary incontinence care designed to restore comfort, rest, and confidence for people living with severe urinary incontinence and for their caregivers.
Every day, Wellspect strives to maintain the highest quality standards while minimizing the environmental impact of its products.
Headquartered in Mölndal, Sweden, Wellspect operates in more than 40 countries, offering life-enhancing solutions to people around the world. Dentsply Sirona, the world’s largest diversified manufacturer of professional dental products and technologies, is listed on Nasdaq under the symbol XRAY.
